By Business Segment
Currently the Group has five reportable segments as follows:
Hospital and healthcare : Singapore, Malaysia, India, Greater China, Turkiye and Europe & Southeast Asia
IMU* : Education service provider in Malaysia
Labs : Diagnostic laboratory service provider in Malaysia and Singapore
PLife REIT : Real Estate Investment Trust
Others : Includes the corporate office
| Financial Year Ended 31 December | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| 12 months Actual (Audited) |
12 months Actual (Audited) |
12 months Actual (Audited) |
12 months Actual (Audited) |
12 months Actual (Audited) |
|
| Presented in RM mil | |||||
| Hospital and Healthcare | 19,739.6 | 16,508.5 | 16,718.4 | 12,996.1 | 14,509.9 |
| 94.29% | 91.77% | 97.59% | 96.95% | 97.30% | |
| IMU* | 53.9 | 260.8 | 257.6 | 248.7 | 259.0 |
| 0.26% | 1.45% | 1.50% | 1.86% | 1.74% | |
| Labs | 982.6 | 1,064.9 | - | - | - |
| 4.69% | 5.92% | - | - | - | |
| PLife REIT | 153.1 | 149.5 | 153.2 | 155.0 | 139.5 |
| 0.73% | 0.83% | 0.89% | 1.16% | 0.94% | |
| Others | 5.7 | 5.0 | 2.6 | 4.9 | 4.1 |
| 0.03% | 0.03% | 0.02% | 0.03% | 0.02% | |
| Total Revenue | 20,934.8 | 17,988.7 | 17,131.8 | 13,404.6 | 14,912.5 |
Note:
| * | Completed divestment of IMU on 31 March 2023 |